Trials / Sponsors / Rui-hua Xu, MD, PhD
Rui-hua Xu, MD, PhD
Academic / Other · 4 registered clinical trials — 4 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Second-line Irinotecan Liposome Combination Regimen for Irinotecan-treated Pancreatic Cancer Pancreatic Cancer | Phase 2 | 2024-11-20 |
| Not Yet Recruiting | Liposomal Irinotecan and 5-FU as Second-line Therapy for Patients With ESCC Esophageal Cancer | Phase 3 | 2024-08-01 |
| Not Yet Recruiting | A Phase lb/lI Clinical Study in Advanced or Metastatic Esophageal Squamous Cell Carcinoma Esophageal Squamous Cell Carcinoma | Phase 2 | 2024-07-10 |
| Not Yet Recruiting | A Phase II Study of Surufatinib Combined With Camrelizumab and mFOLFOX6 as Second-line Treatment for Advanced Advanced Pancreatic Cancer | Phase 2 | 2024-05-22 |